pediatrics

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

neurobiology of disease

biology of blood and marrow transplantation : journal of the american society for blood and marrow transplantation

[1] 13-valent Pneumococcal Conjugate Vaccine in children with acute lymphoblastic leukaemia: protective immunity can be achieved on completion of treatment.

[2] Dietary Interventions for Autism Spectrum Disorder: A Meta-analysis.

[3] Addressing the impact of the Coronavirus Disease (COVID-19) pandemic on hematopoietic cell transplantation: Learning networks as means for sharing best practices.

[4] Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.

[5] case of early-disseminated rhizopus microsporus var. microsporus mucormycosis in a renal transplant patient

[6] pseudomembranous tracheitis caused by aspergillus fumigatus in the setting of high grade t-cell lymphoma

[7] pulmonary nocardiosis and scrub typhus in an immunocompromised host

[8] parasites may exit immunocompromised northern pig-tailed macaques (macaca leonina) infected with sivmac239

[9] Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients

[10] Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

[11] Staphylococcus aureus – antimicrobial resistance and the immunocompromised child

[12] Current management of parainfluenza pneumonitis in immunocompromised patients: a review

[13] Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

[14] Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients

[15] Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

[16] Staphylococcus aureus – antimicrobial resistance and the immunocompromised child

[17] Current management of parainfluenza pneumonitis in immunocompromised patients: a review

[18] Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

[19] Kaposi Sarcoma in Non-immunocompromised Adult.

[20] Galactomannan and PCR in the Central Nervous System to Detect Invasive Mold Disease - A Retrospective Analysis in Immunocompromised Children.

[21] Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.

[22] Molecular epidemiology of Enterocytozoon bieneusi and Encephalitozoon sp., among immunocompromised and immunocompetent subjects in Iran

[23] Emerging Antimicrobial Resistance and the Immunocompromised Host

[24] Viral infections in immunocompromised patients: what's new with respiratory viruses?

[25] Community respiratory virus infections in immunocompromised patients with cancer

[26] Hepatic candidiasis: an increasing problem in immunocompromised patients

[27] Fever in immunocompromised patients

[28] Severe RSV bronchiolitis in an immunocompromised child

[29] Dermatologic infections in the immunocompromised (non-HIV) host

[30] molecular and conventional methods for detection of candida species isolated from a sample of immunocompromised iraqi patients with pulmonary symptoms

[31] invasive actinomycosis: surrogate marker of a poor prognosis in immunocompromised patients

[32] immunocompromised host: from the early events until the impact of acquired immunodeficiency syndrome

[33] necrobiosis lipoidica developing within a surgical scar in a non-diabetic patient: type iii koebner phenomenon (isomorphic response), wolf's isotopic response or ruocco's immunocompromised cutaneous district?

[34] myroides odoratus and chryseobacterium indologenes: two rare isolates in the immunocompromised

[35] prevalence of enteroparasites in immunocompromised and immunocompetent children

[36] molecular detection of pneumocystis jirovecii using polymerase chain reaction in immunocompromised patients with pulmonary disorders in northeast of iran

[37] tratamento pelo fluconazol de pacientes imuno-comprometidos com graves infecções fúngicas treatment by fluconazole of severe fungal infections in immunocompromised patients

[38] treatment of immunocompromised, critically ill patients with influenza a h1n1 infection with a combination of oseltamivir, amantadine, and zanamivir

[39] cd4+ and cd8+ t cell immune responses of immunocompetent and immunocompromised (aids) patients with american tegumentary leishmaniasis

[40] antifungal prophylaxis in immunocompromised patients

[41] disseminated tuberculosis with prostatic abscesses in an immunocompromised patient—a case report and review of literature

[42] pulmonary nocardiosis and scrub typhus in an immunocompromised host

[43] parasites may exit immunocompromised northern pig-tailed macaques (macaca leonina) infected with sivmac239

[44] a rare case of immune reconstitution inflammatory syndrome development in an immunocompromised patient with progressive multifocal leukoencephalopathy and multicentric castleman’s disease

[45] correct identification of ochrobactrum anthropi from blood culture using 16rrna sequencing: a first case report in an immunocompromised patient in mexico

[46] isoscartopic response: another facet of the immunocompromised cutaneous district

[47] Searching for a Bacteriophage Lysin to Treat in Immunocompromised Mice.

[48] Outbreaks of Typhlocolitis Caused by Hypervirulent Group ST1 in Highly Immunocompromised Strains of Mice.

[49] Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus

[50] Outcomes of Immunocompromised Adults Hospitalized With Laboratory-confirmed Influenza in the United States, 2011–2015

[51] Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure

[52] Oxygenation/non-invasive ventilation strategy and risk for intubation in immunocompromised patients with hypoxemic acute respiratory failure

[53] An Opportunity to Better Understand the Impact of Coronaviruses on Immunocompromised Patients

[54] Diagnosis of severe respiratory infections in immunocompromised patients

[55] Acute respiratory failure in immunocompromised adults

[56] High-Flow Nasal Cannula Oxygenation in Immunocompromised Patients With Acute Hypoxemic Respiratory Failure: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study

[57] Chronic asymptomatic SARS-CoV-2 infection in the immunocompromised patient: new challenges and urgent needs

[58] Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial

[59] Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs

[60] The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial - Critical Care

[61] Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis

[62] The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts

[63] The Natural History of Influenza Infection in the Severely Immunocompromised vs Nonimmunocompromised Hosts

[64] Viral community-acquired pneumonia in nonimmunocompromised adults

[65] Chronic Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in the Immunocompromised Patient: New Challenges and Urgent Needs

[66] Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults

[67] Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure - Annals of Intensive Care

[68] 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host

[69] The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial

[70] Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial

[71] The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial

[72] Pulmonary Metagenomic Sequencing Suggests Missed Infections in Immunocompromised Children

[73] Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

[74] DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study